the threat of influenza is formidable
but now so are your vaccine options

Only 2 Vaccines Have Been Proven to Prevent More Cases of Influenza Compared With Standard-Dose Influenza Vaccine Comparators in older adults1-4

Fluzone® High-Dose

vaccine is proven in a head-to-head randomized controlled trial to prevent more cases of influenza compared with Fluzone vaccine in adults 65+1,3

In a randomized controlled trial for immunogenicity and safety, the most common local and systemic adverse reactions to Fluzone High-Dose vaccine include pain at the injection site, myalgia, malaise and headache.5

  • Last flu season, nearly two-thirds of all adults 65+ who were immunized received Fluzone High-Dose vaccine6
  • Since 2010, more than 110 million doses of Fluzone High-Dose vaccine have been sold in the United States7

Flublok® Quadrivalent

vaccine is proven in a head-to-head randomized controlled trial to prevent more cases of influenza compared with a standard-dose quadrivalent inactivated vaccine in adults 50+2,4

In this randomized controlled trial, the most common local and systemic adverse reactions to Flublok Quadrivalent vaccine include pain at the injection site, headache and fatigue.2,4

  • FDA-licensed recombinant hemagglutinin (HA) influenza vaccine, which replicates all 4 recommended HA strains exactly2
  • 3X the HA (45 mcg HA) of a standard-dose quadrivalent inactivated vaccine per strain2


Fluzone® Quadrivalent vaccine for patients 6+ monthsa
  • 4-strain defense that helps protect patients 6+ months8

a0.25-mL dose indicated for persons 6 months through 35 months.8

INDICATION FOR FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT, AND FLUZONE HIGH-DOSE VACCINES

Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines are indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus(es) contained in each vaccine. Flublok Quadrivalent vaccine is approved for use in persons 18 years of age and older. Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older. Fluzone High-Dose vaccine is approved for use in persons 65 years of age and older.

You are about to leave
Sanofiflu.com

You are being directed to VaccineShoppe.com®.
Would you like to continue?